Catherine McBain is a Consultant Clinical Oncologist at The Christie NHS FT where she subspecialises in adult Neuro-oncology. She is Clinical Lead for the Greater Manchester Cancer Brain and CNS Pathway Board and works with Macmillan Cancer Support as Senior Editor for Neuro-oncology. Her clinical practice comprises the management of adult patients with primary brain and spinal tumours, aswell as that growing subgroup of patients with brain metastases who are referred for consideration of neurosurgery or stereotactic radiosurgery. She is the lead for Neuro-oncology clinical trials at The Christie, with a personal focus on novel agents for glioblastoma. She helped to establish the stereotactic radiosurgery service at Salford Royal FT and continues to develop that service in response to the changing landscape of brain metastases care. She also works within the Base of Skull service and the NF2 Regional Genetics Service, and collaborates with her colleagues who deliver Proton Beam Therapy at The Christie.
Catherine has served several terms on the NCRI Brain Clinical Subgroup Group, and continues as a member of its Supportive Care subcommittee, aswell as contributing to other events including its Brain Metastases workshops.
She is passionate about improving care and outcomes for brain tumour patients, via clinical trials as well as via supportive and holistic care. Her particular interests are in clinical trials of immunotherapy and novel agents for gliomas. She is keen to increase interaction between the neuro-oncology community and the early-phase trials community and to ensure that glioma patients are included in personalised medicine advances including tumour agnostic drug developments.